{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:24:46Z","timestamp":1781796286319,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["212516\/Z\/18\/Z"],"award-info":[{"award-number":["212516\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UKRI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["17DD08"],"award-info":[{"award-number":["17DD08"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Children's Charity","doi-asserted-by":"publisher","award":["COVID_CSmith_017"],"award-info":[{"award-number":["COVID_CSmith_017"]}],"id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009323","name":"Animal Free Research UK","doi-asserted-by":"publisher","award":["AFR19-20274"],"award-info":[{"award-number":["AFR19-20274"]}],"id":[{"id":"10.13039\/501100009323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.mucimm.2023.11.007","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T09:45:30Z","timestamp":1700819130000},"page":"124-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5012-4277","authenticated-orcid":false,"given":"Samuel","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2827-6024","authenticated-orcid":false,"given":"Miranda","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0782-2715","authenticated-orcid":false,"given":"Alice","family":"Burleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Doykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Japhette","family":"Kembou-Ringert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4511-9171","authenticated-orcid":false,"given":"Maximillian","family":"Woodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-8965","authenticated-orcid":false,"given":"Tereza","family":"Masonou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2078-9451","authenticated-orcid":false,"given":"Katie-Marie","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo Torres","family":"Ortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2915-1067","authenticated-orcid":false,"given":"Antonio","family":"Casal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-7757","authenticated-orcid":false,"given":"Sudaxshina","family":"Murdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-8791","authenticated-orcid":false,"given":"Robert E.","family":"Hynds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-3958","authenticated-orcid":false,"given":"Kimberly C.","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cortina-Borja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-8760","authenticated-orcid":false,"given":"Wendy E","family":"Heywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8913-0009","authenticated-orcid":false,"given":"Claire M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2023.11.007_b0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: the major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.mucimm.2023.11.007_b0010","doi-asserted-by":"crossref","first-page":"e0263419","DOI":"10.1371\/journal.pone.0263419","article-title":"Saliva as a useful tool for evaluating upper mucosal antibody response to influenza","volume":"17","author":"Tsunetsugu-Yokota","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mucimm.2023.11.007_b0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jmv.20173","article-title":"Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus","volume":"74","author":"Asahi-Ozaki","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/v14020187","article-title":"Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence","volume":"14","author":"Focosi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.mucimm.2023.11.007_b0025","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41467-021-22034-1","article-title":"SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mucimm.2023.11.007_b0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.mucimm.2023.11.007_b0035","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/s41467-020-19943-y","article-title":"Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mucimm.2023.11.007_b0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cmi.2020.10.020","article-title":"SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis","volume":"27","author":"Rostami","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mucimm.2023.11.007_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957107","article-title":"Mucosal immunity: the missing link in comprehending SARS-CoV-2 infection and transmission","volume":"13","author":"Russell","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104585","article-title":"Mucosal vaccines for SARS-CoV-2: triumph of hope over experience","volume":"92","author":"Pilapitiya","year":"2023","journal-title":"EBiomedicine"},{"key":"10.1016\/j.mucimm.2023.11.007_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QCO.0000000000000724","article-title":"Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection","volume":"34","author":"Fr\u00f6berg","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.11.007_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jobcr.2015.08.006","article-title":"Saliva as a diagnostic tool for oral and systemic diseases","volume":"6","author":"Javaid","year":"2016","journal-title":"J. Oral Biol. Craniofac. Res."},{"key":"10.1016\/j.mucimm.2023.11.007_b0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/oem.2006.026567","article-title":"The use of salivary biomarkers in occupational and environmental medicine","volume":"64","author":"Soo-Quee","year":"2007","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.mucimm.2023.11.007_b0070","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.3390\/ijms13044295","article-title":"Salivary defense proteins: their network and role in innate and acquired oral immunity","volume":"13","author":"F\u00e1bi\u00e1n","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mucimm.2023.11.007_b0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000358783","article-title":"Antimicrobial defense systems in saliva","volume":"24","author":"van 't Hof","year":"2014","journal-title":"Monogr. Oral Sci."},{"key":"10.1016\/j.mucimm.2023.11.007_b0080","unstructured":"Great Ormond Street Hospital for Children. Seen and heard \u2013 diversity and inclusion annual report. https:\/\/www.gosh.nhs.uk\/about-us\/diversity-and-inclusion\/ (2022) [Date accessed: 18 August 2021]."},{"key":"10.1016\/j.mucimm.2023.11.007_b0085","article-title":"The UK\u2019s public health response to Covid-19","volume":"369","author":"Scally","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.mucimm.2023.11.007_b0090","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/cid\/ciab607","article-title":"Long-term persistence of spike protein antibody and predictive modeling of antibody dynamics after infection with severe acute respiratory syndrome coronavirus 2","volume":"74","author":"Grandjean","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.11.007_b0095","article-title":"Vimentin is an important ACE2 co-receptor for SARS-CoV-2 in epithelial cells","volume":"11","author":"Arrindell","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.mucimm.2023.11.007_b0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113874119","article-title":"Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells","volume":"119","author":"Amraei","year":"2022","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.1016\/j.mucimm.2023.11.007_b0105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1099\/jgv.0.001453","article-title":"SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology","volume":"101","author":"Ogando","year":"2020","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0110","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1113\/JP281499","article-title":"Human models for COVID-19 research","volume":"599","author":"Woodall","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2021.01.073","article-title":"The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients","volume":"543","author":"Smits","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mucimm.2023.11.007_b0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/jiab256","article-title":"Persisting salivary IgG against SARS-CoV-2 at 9 months after mild COVID-19: A complementary approach to population surveys","volume":"224","author":"Alkharaan","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.11.007_b0130","article-title":"Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19","author":"Varadhachary","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.mucimm.2023.11.007_b0135","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.chom.2022.01.003","article-title":"Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections","volume":"30","author":"Terreri","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mucimm.2023.11.007_b0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0145","doi-asserted-by":"crossref","first-page":"eabe5511","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/imm.13349","article-title":"Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva","volume":"164","author":"Faustini","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.mucimm.2023.11.007_b0155","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1038\/s41598-022-12869-z","article-title":"Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity","volume":"12","author":"Thomas","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mucimm.2023.11.007_b0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","article-title":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19","volume":"147","author":"Cervia","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0165","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mucimm.2023.11.007_b0170","doi-asserted-by":"crossref","first-page":"e0249979","DOI":"10.1371\/journal.pone.0249979","article-title":"Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva","volume":"16","author":"Tsukinoki","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mucimm.2023.11.007_b0175","doi-asserted-by":"crossref","first-page":"e0266958","DOI":"10.1371\/journal.pone.0266958","article-title":"Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: a mixed effects model across two vaccination periods","volume":"17","author":"Anastassopoulou","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mucimm.2023.11.007_b0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.mucimm.2023.11.007_b0185","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/gut.33.7.882","article-title":"Immunosenescence and mucosal immunity: significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts","volume":"33","author":"Arranz","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.mucimm.2023.11.007_b0190","article-title":"Disparities of SARS-CoV-2 nucleoprotein-specific IgG in healthcare workers in East London, UK","volume":"8","author":"Choudhry","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.mucimm.2023.11.007_b0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12916-022-02286-4","article-title":"Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (Covidence UK)","volume":"20","author":"Talaei","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.mucimm.2023.11.007_b0200","doi-asserted-by":"crossref","first-page":"e000872","DOI":"10.1136\/bmjresp-2020-000872","article-title":"Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response","volume":"8","author":"Shields","year":"2021","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.mucimm.2023.11.007_b0205","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(21)00634-6","article-title":"Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform","volume":"397","author":"Mathur","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.mucimm.2023.11.007_b0210","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mucimm.2023.11.007_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820250","article-title":"Natural SARS-CoV-2 infection affects neutralizing activity in saliva of vaccines","volume":"13","author":"Garziano","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0220","article-title":"Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response","volume":"2","author":"Doykov","year":"2022","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.mucimm.2023.11.007_b0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/iovs.63.6.16","article-title":"Lysozyme protects against severe acute respiratory syndrome coronavirus 2 infection and inflammation in human corneal epithelial cells","volume":"63","author":"Song","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mucimm.2023.11.007_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103592","article-title":"Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease","volume":"25","author":"Costa-da-Silva","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.mucimm.2023.11.007_b0235","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1038\/s41598-022-10559-4","article-title":"Protein-bound sialic acid in saliva contributes directly to salivary anti-influenza virus activity","volume":"12","author":"Kobayashi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mucimm.2023.11.007_b0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1399-302X.2008.00468.x","article-title":"Multiple components contribute to ability of saliva to inhibit influenza viruses","volume":"24","author":"White","year":"2009","journal-title":"Oral Microbiol. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0245","doi-asserted-by":"crossref","first-page":"e0089222","DOI":"10.1128\/mbio.00892-22","article-title":"Serine protease inhibitors restrict host susceptibility to SARS-CoV-2 infections","volume":"13","author":"Rosendal","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.mucimm.2023.11.007_b0250","first-page":"90","article-title":"S100A8\/A9 in COVID-19 pathogenesis: impact on clinical outcomes","volume":"63","author":"Mellett","year":"2022"},{"key":"10.1016\/j.mucimm.2023.11.007_b0255","doi-asserted-by":"crossref","first-page":"e68694","DOI":"10.1371\/journal.pone.0068694","article-title":"High levels of S100A8\/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling","volume":"8","author":"Kuipers","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mucimm.2023.11.007_b0260","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2022.02.003","article-title":"Vimentin: regulation and pathogenesis","volume":"197","author":"Paulin","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.mucimm.2023.11.007_b0265","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1038\/s41598-022-11248-y","article-title":"Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia","volume":"12","author":"Lalioti","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mucimm.2023.11.007_b0270","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.3390\/ijms21134675","article-title":"Vimentin as a multifaceted player and potential therapeutic target in viral infections","volume":"21","author":"Ramos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mucimm.2023.11.007_b0275","doi-asserted-by":"crossref","first-page":"1224352","DOI":"10.3389\/fimmu.2023.1224352","article-title":"Vimentin: from a cytoskeletal protein to a critical modulator of immune response and a target for infection","volume":"14","author":"Arrindell","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12929-016-0234-7","article-title":"Surface vimentin is critical for the cell entry of SARS-CoV","volume":"23","author":"Yu","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.mucimm.2023.11.007_b0285","doi-asserted-by":"crossref","first-page":"34172","DOI":"10.1021\/acsami.3c03347","article-title":"Physicochemical nature of SARS-CoV-2 spike protein binding to human vimentin","volume":"15","author":"Deptu\u0142a","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mucimm.2023.11.007_b0290","doi-asserted-by":"crossref","first-page":"e2105640","DOI":"10.1002\/smll.202105640","article-title":"Extracellular vimentin as a target against SARS-CoV-2 host cell invasion","volume":"18","author":"Suprewicz","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.mucimm.2023.11.007_b0295","doi-asserted-by":"crossref","first-page":"e000623","DOI":"10.1136\/bmjresp-2020-000623","article-title":"Vimentin as a target for the treatment of COVID-19","volume":"7","author":"Li","year":"2020","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.mucimm.2023.11.007_b0300","doi-asserted-by":"crossref","first-page":"e0254221","DOI":"10.1128\/mBio.02542-21","article-title":"A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseases","volume":"12","author":"Li","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.mucimm.2023.11.007_b0305","doi-asserted-by":"crossref","first-page":"4215097","DOI":"10.1155\/2022\/4215097","article-title":"2D-DIGE-based proteomic profiling with validations identifies vimentin as a secretory biomarker useful for early detection and poor prognosis in oral cancers","volume":"2022","author":"Sivagnanam","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0310","doi-asserted-by":"crossref","first-page":"jcs250597","DOI":"10.1242\/jcs.250597","article-title":"The diverse roles and dynamic rearrangement of vimentin during viral infection","volume":"134","author":"Zhang","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mucimm.2023.11.007_b0315","article-title":"Comparison of biomarkers in blood and saliva in healthy adults","volume":"2012","author":"Williamson","year":"2012","journal-title":"Nurs. Res. Pract."},{"key":"10.1016\/j.mucimm.2023.11.007_b0320","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jim.2005.09.010","article-title":"Impact of saliva collection methods on sIgA and cortisol assays and acceptability to participants","volume":"307","author":"Strazdins","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.mucimm.2023.11.007_b0325","doi-asserted-by":"crossref","first-page":"e0206059","DOI":"10.1371\/journal.pone.0206059","article-title":"Salivary immunity and lower respiratory tract infections in non-elite marathon runners","volume":"13","author":"Cant\u00f3","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mucimm.2023.11.007_b0330","doi-asserted-by":"crossref","first-page":"e22802","DOI":"10.1097\/MD.0000000000022802","article-title":"Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia","volume":"99","author":"Proc","year":"2020","journal-title":"Med. (Baltim.)"},{"key":"10.1016\/j.mucimm.2023.11.007_b0335","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41423-021-00700-0","article-title":"Cross-reactive antibody immunity against SARS-CoV-2 in children and adults","volume":"18","author":"Fraley","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0340","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/1348-0421.13011","article-title":"Prevalence of saliva immunoglobulin A antibodies reactive with severe acute respiratory syndrome coronavirus 2 among Japanese people unexposed to the virus","volume":"66","author":"Tsukinoki","year":"2022","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.mucimm.2023.11.007_b0345","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12575-016-0045-y","article-title":"An optimised method for the proteomic profiling of full thickness human skin","volume":"18","author":"Bliss","year":"2016","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.mucimm.2023.11.007_b0350","article-title":"The emergence of goblet inflammatory or ITGB6hi nasal progenitor cells determines age-associated SARS-CoV-2 pathogenesis","author":"Woodall","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.mucimm.2023.11.007_b0355","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mucimm.2023.11.007_b0360","unstructured":"RStudio Team. RStudio: integrated development for R. RStudio, Inc. Available at: http:\/\/www.rstudio.com\/ (2015). [Date accessed: 20 October 2023]."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021923000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021923000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T15:26:00Z","timestamp":1717341960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021923000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1933021923000909"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2023.11.007","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2023.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}